Remedium Lifecare Hits 52-Week Low, Underperforming Sector and Market
Remedium Lifecare, a microcap company in the trading industry, has hit a 52-week low on August 13, 2024, with a stock price of Rs.10.3. This marks the eighth consecutive day of losses for the company, with a decline of -26.33% in this period. It has also underperformed the sector and the overall market in the past year. Investors should carefully consider their options before making any decisions regarding this stock.
Remedium Lifecare, a microcap company in the trading industry, has recently hit a 52-week low on August 13, 2024. This news has been confirmed by MarketsMOJO, who has given a "Sell" call for the stock.
The stock price of Remedium Lifecare has reached a new low of Rs.10.3, underperforming the sector by -4.21% on the same day. This marks the eighth consecutive day of losses for the company, with a significant decline of -26.33% in this period. The stock is also currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In the past year, Remedium Lifecare has seen a decline of -74.40% in its performance, while the Sensex has shown a growth of 21.81%. This indicates a significant underperformance by the company in comparison to the overall market.
As a microcap company in the trading industry, Remedium Lifecare may face challenges in the current market conditions. Investors should carefully consider their options before making any decisions regarding this stock. This news is for informational purposes only and does not constitute any recommendation or expert opinion. It is based on factual data and should not be interpreted as a prediction of future potential.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
